Chandrakanta, Nagayach, Sonkar, Bharti, and Kumar: Ki-67 expression in human oral squamous cell carcinoma


Introduction

Oral cancers are one of the ten leading cancers in the world. However, in India, it is one of the most common cancers and constitutes a major public health problem.1 Oral squamous cell carcinoma is a well-known malignancy that accounts for more than 90% of all oral cancers.2 Some of the important risk factors for oral squamous cell carcinoma are use of tobacco or betel quid and regular drinking of alcoholic beverages. The mutagenic effects of tobacco, alcohol, betel quid or areca-nut are dependent upon dose, frequency and duration of use and are accelerated and exaggerated by the concurrent use of two or more of these agents.3 However, high-risk human papillomavirus (HPV) genotypes also appear to play an etiologic role in many cancers of the oropharynx and possibly a small subgroup of cancers of the oral cavity.4 The mean age of occurrence of cancer in different parts of oral cavity is usually between 51-55 years in most countries. The tongue is the leading site, among oral cancers, in India. Other important sites in Asian countries include the buccal mucosa and gingiva. The 5 year survival rate has been low for oral cancers, despite improvements in diagnosis and treatment.5 Generally oral squamous cell carcinomas metastasize early and are associated with a poor survival rate. Their prevention largely depends on timeous identification of precancerous oral mucosal lesions, which may present clinically as a homogeneous or nodular white plaque (leukoplakia), a mixed white and red lesion (erythroleukoplakia) or a homogeneous or nodular red lesion (erythroplakia). Red premalignant lesions, generally, have a higher malignant potential than white lesions.6 Oral squamous cell carcinoma in its initial stages shows an erytholeukoplastic area without symptoms, but in advanced stages there are ulcers and lumps with irregular margins, which are rigid to touch. The differential diagnosis should be established with other oral malignant diseases such as lymphomas, sarcomas and metastasis, which have rapid growth rates as opposed to the typical Oral SCC.7 Ki-67 is a cell cycle associated human nuclear protein present in peri-chromosomal region, the expression of which strictly associated with cell proliferation and which is widely used in pathology as a proliferation marker to measure the growth fraction of cells in human tumors.8

Aim and Objectives

The present study was done to assess the expression of KI-67 immunohistochemically in various histological grades of oral squamous cell carcinoma (OSCC) cases in various sites of OSCC.

Materials and Methods

The study is carried out on 40 biopsy samples (38 cases of biopsy proven squamous cell carcinomas and 02 normal oral mucosa biopsy specimens) of oral mucosa, in our Department of Pathology. Tissue fragments were fixed in 10% formalin and processed by the usual histopathological technique for paraffin embedding and H&E staining. Clinical and histological data were analyzed and the classification of lesions was done. The immunohistochemical processing was made on serial sections, using with DAKO FLEX monoclonal mouse antihuman Ki-67 antibody, and the signal detection was performed with DAB (3,3’-diaminobenzidine, Dako).

Immunostaining evaluation and quantification

The criterion used to define KI-67 positive cells was: epithelial cells showing brown nucleoplasm staining. KI-67 activity was quantified by selecting the most densely and evenly labelled areas in the sections and assessing the labeling index (LI) from the ratio of number of cells stained by KI-67 to the total number of cells (minimum of 1000 cells in two to four consecutive fields at high power (40X), the result being multiplied by 100.

Observation and Results

Patients belonged to a wide range of age groups, from 2rd to 8th decade of life. However maximum numbers of patients were from 4th to 7th decade in our study (Table 1). Thirty-eight cases of OSCC were observed, out of which 31 (81.57%) were male, and 07 (18.42%) cases were female. We have observed OSCC to be more common in males. The most common site was tongue (50%), followed by buccal mucosa (18.42%); 06 patients (15.78%) had lesion at palate. Two patients (5.26%) had lesions at different sites in oral cavity such as retromolar trigone and tonsillar area (Table 2). Thirty-eight cases of OSCC were observed, out of which 35 (92.10%) cases had a significant history of tobacco use/smoking, whereas 03 (7.89%) did not have any history of tobacco use. We observed Ki-67 LI for normal oral mucosa was 14 ± 5.6%. In well-differentiated carcinoma, the KI-67 LI was 28.52 ± 21.25%, which increased to 42.85 ± 18.2% in moderately differentiated carcinoma and 68.57 ± 17.6% in poorly differentiated carcinoma. We noticed that Ki-67 acts as an excellent marker of cellular proliferation. There is a statistical difference in KI-67 overexpression between various grades of OSCC and normal oral mucosa (p value <0.05) (Table 3). We noted Ki-67 LI was 46.83 ± 26.82% at palate and 45.68 ± 24.19% at tongue. The Ki-67 expression was higher in buccal mucosa (62.53±17.23%) as compared to other anatomical sites (Table 3).

Figure 1

Photo micrographs of various grades of SCC; Well differentiated squamous cell carcinoma, (a: H&E & d: Ki-67), 40X. Moderately differentiated squamous cell carcinoma (b: H&E & e: Ki-67), 40X. Poorly differentiated squamous cell carcinoma (c: H&E & f: Ki-67), 40X.

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/50c858aa-48fc-4335-9a3f-ecf7045aafe1/image/9b0fb2f6-a457-4e01-998e-56d4d38fd867-uimage.png

Table 1

Age distribution of patients of oral SCC

Age group (years)

No. of cases

Percentage

0-10 years

00

0%

11-20 years

00

0%

21-30 years

04

10.52%

31-40 years

08

21.05%

41-50 years

09

23.68%

51-60 years

08

21.05%

61-70 years

08

21.05%

71-80 years

01

2.63%

Total

38

100%

Table 2

Distribution of OSCC cases according to site in oral cavity

Tumour location

No. of cases

Percentage

Buccal mucosa

07

18.42%

Tongue

19

50%

Gingiva

04

10.52%

Palate

06

15.78%

Other sites

02

5.26%

Total

38

100%

Table 3

Ki-67 expression in normal oral mucosa and different histological grades of OSCC, and comparison of ki-67 expression with anatomical site of OSCC

Type of lesion

No. of cases

Ki-67 labelling index scores ± SD

Normal oral mucosa

02

14 ± 5.6%

WDSCC

10

28.52 ± 21.25%

MDSCC

21

42.85 ± 18.2%

PDSCC

07

68.57 ± 17.6%

Site of lesion

No of cases

Ki-67 labelling index scores ± SD

Palate

06

46.83 ± 26.82%

Tongue

19

45.68 ± 24.19%

Buccal mucosa

07

62.53 ± 17.23%

Gingiva

04

39.28 ± 19.31%

Others

02

43.00 ± 11.18%

Discussion

In the present study 40 cases were included, 02 cases were of normal oral mucosa and 38 cases were of OSCC. In squamous cell carcinoma 10 cases were of well differentiated squamous cell carcinoma, 21 cases were of moderately differentiated squamous cell carcinoma, and 07 cases were of poorly differentiated squamous cell carcinoma.

In present study, age range for OSCC were from 2nd decade to 8th decade with maximum number of cases in 3rd to 6th decade; whereas Sharma P et al9 observed that large number of cases developed in the 4th and 5th decades of life. Shenoi R et al1 found the largest number of cases were in age group of 51-60 years followed by age group 41-50 years. Krishna Rao SV et al5 observed mean age of occurrence of cancer 51-55 years in most countries.

We found OSCC to be more common in males (31 out of 38 cases); which was concurrent with other studies by Sharma P et al9 who observed 80 oral SCC patients & found that men represented a higher proportion (68.7%) of oral SCCs than women (31.2%) and Shenoi R et al.1 found that OSCC was more common in men.

We observed that tongue was the most common site (50%), followed by buccal mucosa (18.42%); which was similar to Krishna Rao SV et al5 who observed that tongue is the leading site, among oral cancers, in India, other important sites in Asian countries include the buccal mucosa and gingiva; whereas Sharma P et al.9 found that buccal mucosa was the most common site involved (63.75%) while the palate showed the least incidence (2.5%). Shenoi R et al.1 observed mandibular alveolus as the most frequently involved site, accounting for 135 cases (45.76%), followed by buccal mucosa 70 cases (23.73%).

We observed that OSCC was more common (35 out of 38 cases) in patients with history of tobacco intake/smoking habit; which was similar to study by Sharma P et al9 who revealed that larger number of patients had the smokeless tobacco habit (60%) than the bidi or cigarette smoking habit (36.25%), Shenoi R et al.1 revealed that most of the patients (31.86%) were tobacco chewers; this was followed by those who had the habit of both tobacco chewing and smoking which represented 18.64%. 15.93% were addicted to smoking alone, 15.03% had habit of all the three smoking, tobacco chewing and consumption of alcohol. 7.12% to tobacco chewing and alcohol, 5.42% were addicted to alcohol but were not consuming tobacco in any form. A small group of the patients 5.08% did not have any of these three habits.

Positive Ki-67 staining was seen in all specimens of normal mucosa, WDSCC, MDSCC and PDSCC. We observed Ki-67 LI for normal oral mucosa was 14 ± 5.6%. In well-differentiated carcinoma, the KI-67 LI was 28.52 ± 21.25%, which increased to 42.85 ± 18.2% in moderately differentiated carcinoma and 68.57 ± 17.6% in poorly differentiated carcinoma. We noticed that Ki-67 acts as an excellent marker of cellular proliferation. There is a statistical difference in KI-67 overexpression between various grades of OSCC and normal oral mucosa (p value <0.05). Premalatha et al10 also noted increasing trend in the mean Ki-67 LI with higher Broder’s grade and observed positive association with the histologic grading in human OSCC. Vandana et al11 observed that mean Ki-67 labelling index score was 8.47±1.586 in healthy oral mucosa, 25.5±3.01 in premalignancy, and 29.7±3.04 in squamous cell carcinoma. S. Humayun et al12 studied expression of ki-67 increases as normal oral mucosa becomes dysplastic and undergoes malignant transformation. Janti S et al13 studied highest Ki-67 positive index was for squamous cell carcinoma (64.55 ±23.55%) followed by papilloma (23.33 ± 6.94%), gingival polyps (7.06 ± 7.43%) and gingival hypertrophy (1.40 ± 2.80%). One-way ANOVA showed significant differences in Ki-67 expression between neoplastic and non-neoplastic samples (p<0.05). Olimid et al.14 analyzed Ki67 immunoexpression in 44 OSCCs from various anatomical sites. Ki67 immunoreaction was identified in all analyzed cases and presented an index of proliferation of 22% for well-differentiated carcinomas, 32% for moderately differentiated and 53% for the poorly differentiated ones. Dwivedi et al.15 evaluated layer wise expression of Ki‑67 in oral epithelial dysplasia and in OSCC. The mean Ki‑67 LI was 12.78 for low risk lesions, 28.68 for high risk lesions, 39.45 for OSCC and 13.6 for normal buccal mucosa. Viswanathan V et al.16 evaluated the role and significance of apoptotic indices (AI) and proliferative indices (PI) in premalignant and malignant squamous cell lesions of the oral cavity. PI also was found to increase significantly from 35.58 ± 19.40% in well differentiated carcinoma to 69.10 ± 9.95% in moderately differentiated carcinoma and 85.95 ± 9.97% in poorly differentiated carcinoma. The highest PI was seen in poorly differentiated SCC. Verma R et al.17 reported higher Ki-67 expression was seen in OSCC group as compared to normal mucosa. Rakheja M et al.18 found highly significant correlation was found between Ki-67 expression and the advancing grades of OSCC. H We et al19 found positive expression rate of Ki-67 protein in normal oral mucosa, oral leukoplakia and OSCC was 30%, 56.3% and 79.2%, respectively. The expression of Ki-67 protein was significantly elevated with tumor stage, differentiation and cervical lymph node metastasis (P<0.05). Tumuluri V et al.20 showed that the Ki-67 proliferative indices obtained correlated with the histological grading of OSCC. These results shows that Ki-67 acts as an excellent marker of cellular proliferation and its expression is associated with the progression of the disease.

We observed 06 cases of palate, 19 cases of tongue, 07 cases of buccal mucosa & 04 cases of gingiva. The Ki-67 LI was higher in buccal mucosa (62.53±17.23%) as compared to (46.83 ± 26.82% in palate and 45.68 ± 24.19% in tongue. There is no significant statistical difference in Ki-67 LI in palate and tongue (p value >0.05). However, Lim et al.21 reported that there was no correlation between proliferative index and factors like age, sex and tumor location.

Conclusion

Our study shows that the tumor cell proliferation as measured by Ki-67 LI at randomly selected fields has a positive association with histologic grading in human oral squamous cell carcinoma and is not associated with patients age and gender of patients. These findings ascertain that Ki-67 antigen can be used to determine the tumor behavior and prognosis in incisional biopsy material. Further studies considering a greater sample size and with other variants of human OSCC should be done to explore differences in their biological behavior and studies correlating the clinical course of the different histological grades of OSCC with their mean Ki-67 LI would be useful as prognostic indicators.

Limitation

  1. This study included only few participants due to limited time period, so generalizability can be questioned.

  2. Articles related to some variables were not found. Due to this difficulty occur in discussion.

Source of Funding

None.

Conflict of Interest

The authors declare no conflict of interest.

References

1 

R Shenoi V Devrukhkar Chaudhuri BK Sharma SB Sapre A Chikhale Demographic and clinical profile of oral squamous cell carcinoma patients: A retrospective studyIndian J Cancer201249216

2 

L Feller J Lemmer Oral Squamous Cell Carcinoma: Epidemiology, Clinical Presentation and TreatmentJ Cancer Ther201242638

3 

S Petti Lifestyle risk factors for oral cancerOral Oncol2009454-534050

4 

R Herrero X Castellsagué M Pawlita J Lissowska F Kee P Balaram Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter studyJ Natl Cancer Inst20039523177283

5 

SVK Rao G Mejia K Roberts-Thomson R Logan Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012)Asian Pac J Cancer Prev20001410556777

6 

EJ Raubenheimer PI DeVilliers Clinical manifestations of oral precancer and cancerJ Dent Assoc S Afr1989Suppl 1114

7 

J Bagan G Sarrion Y Jimenez Oral cancer: clinical featuresOral Oncol20104664147

8 

C Schlüter M Duchrow C Wohlenberg MH Becker G Key HD Flad The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteinsJ Cell Biol1993123351322

9 

P Sharma S Saxena P Aggarwal Trends in the epidemiology of oral squamous cell carcinoma in Western UP: an institutional studyIndian J Dent Res20102133169

10 

BR Premalatha K Uma Analysis of KI-67 antigen in human Oral Squamous Cell Carcinoma – An Immunohistochemical StudyJ. Int Oral Health2010

11 

MV Reddy S Saxena Assessment of Ki-67 in Healthy, Premalignant, and Malignant Lesions of the Oral Mucosa and its Predictive Role in Disease ProgressionInt J Oral-Med Sci2010926774

12 

S Humayun VR Prasad Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical studyNatl J Maxillofac Surg2011213846

13 

J Sudiono I Hassan Low Ki-67 gene expression in non-neoplastic proliferation of oral mucosal epitheliumUniv Med20123115966

14 

DA Olimid CE Simionescu CL Argaritescu A Florescu Immunoexpression of Ki67 and cyclin D1 in oral squamous carcinomasRom J Morphol Embryol2012533 Suppl7958

15 

N Dwivedi S Chandra B Kashyap V Raj A Agarwal Suprabasal expression of Ki-67 as a marker for the severity of oral epithelial dysplasia and oral squamous cell carcinomaContemp Clin Dent201341712

16 

V Viswanathan R Juluri S Goel J Madan SK Mitra D Gopalakrishnan Apoptotic index and proliferative index in premalignant and malignant squamous cell lesions of the oral cavityJ Int Oral Health201571403

17 

R Verma A Singh R Jaiswal A Chandra R Verma J Tak Association of Ki-67 antigen and p53 protein at invasive tumor front of oral squamous cell carcinomaIndian J Pathol Microbiol20145745537

18 

R Mahima P Singh KS Ankur G Vasudeva SC Monica Assessment of Proliferative Potential of Tumor Cells using Ki-67 Expression and Morphometrical Analysis for Prognostication of Oral Squamous Cell Carcinomas Int J Med Res Health Sci2015448206

19 

W He Y Xiao WM Chen Expression of Ki-67 and P53 protein in oral squamous cell carcinoma and its clinical significanceShanghai Kou Qiang Yi Xue201524222831

20 

V Tumuluri GA Thomas IS Fraser Analysis of the Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinomaJ Oral Pathol Med20023110598604

21 

JJ Lim S Kang MR Lee HK Pai Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosisJ Oral Pathol Med200332955261PMID



jats-html.xsl

© This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


  • Article highlights
  • Article tables
  • Article images

Article History

Received : 15-07-2021

Accepted : 02-09-2021

Available online : 23-11-2021


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijpo.2021.098


Article Metrics






Article Access statistics

Viewed: 57

PDF Downloaded: 8



Wiki in hindi